The role of ion content and cell volume in insulin action

1994 ◽  
Vol 22 (2) ◽  
pp. 516-522 ◽  
Author(s):  
Loranne Agius ◽  
Matthew Peak ◽  
Guy Beresford ◽  
Molham Al-Habori ◽  
Trevor H. Thomas
2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Michele Bonus ◽  
Dieter Häussinger ◽  
Holger Gohlke

Abstract Liver cell hydration (cell volume) is dynamic and can change within minutes under the influence of hormones, nutrients, and oxidative stress. Such volume changes were identified as a novel and important modulator of cell function. It provides an early example for the interaction between a physical parameter (cell volume) on the one hand and metabolism, transport, and gene expression on the other. Such events involve mechanotransduction (osmosensing) which triggers signaling cascades towards liver function (osmosignaling). This article reviews our own work on this topic with emphasis on the role of β1 integrins as (osmo-)mechanosensors in the liver, but also on their role in bile acid signaling.


1996 ◽  
Vol 432 (3) ◽  
pp. 571-573 ◽  
Author(s):  
Yoshinori Marunaka ◽  
Yutaka Shintani ◽  
Eizo Sugimoto ◽  
Naomi Niisato

1987 ◽  
Vol 242 (3) ◽  
pp. 655-660 ◽  
Author(s):  
M J Fisher ◽  
A J Dickson ◽  
C I Pogson

The stimulation of phenylalanine hydroxylation in isolated liver cells by sub-maximally effective concentrations of glucagon (less than 0.1 microM) is antagonized by insulin (0.1 nM-0.1 microM). This phenomenon is a consequence of a decrease in the glucagon-stimulated phosphorylation of phenylalanine hydroxylase from liver cells incubated in the presence of insulin. The impact of insulin on the phosphorylation state and activity of the hydroxylase is mimicked by incubation of liver cells in the presence of orthovanadate (10 microM). A series of cyclic AMP and cyclic GMP analogues enhanced phenylalanine hydroxylation: in each case insulin diminished the stimulation of flux. These results are discussed in the light of the characteristics of insulin action on other metabolic processes.


2006 ◽  
Vol 187 (1-2) ◽  
pp. 5-19 ◽  
Author(s):  
C. F. Rossow ◽  
D. Duan ◽  
W. J. Hatton ◽  
F. Britton ◽  
J. R. Hume ◽  
...  

1997 ◽  
Vol 9 (1) ◽  
pp. 18-32 ◽  
Author(s):  
Craig A. Horswill ◽  
William B. Zipf ◽  
C. Lawrence Kien ◽  
E. Bowie Kahle

Insulin is an anabolic hormone with stimulatory effects on glucose and amino acid uptake, possibly protein synthesis, and bone growth, and inhibitory effects on protein breakdown. The precise role of insulin in the growth of healthy children is unclear, but two clinical models can be examined to illustrate insulin’s potential role in the growth of children. The cystic fibrosis (CF) patient, who exhibits poor linear growth and low lean body mass, may exhibit inadequate insulin secretion or impaired insulin action. The obese child typically has an excess of peripheral insulin, an associated acceleration of linear growth, and an accretion of lean body mass and adipose tissue. Speculation is offered on the putative role of exercise in affecting insulin action and secretion, which in turn could impact growth in children with CF or obesity.


Sign in / Sign up

Export Citation Format

Share Document